Social Determinants of Cardiovascular Disease | Tiffany M. Powell-Wiley et al. | ResearchPod

Transcript: Social Determinants of Cardiovascular Disease

[[RP_SECTION:social-determinants-as-biological-stress|Social determinants as biological stressors]]

Alex: [steady, analytical, moderate pace] A review by Tiffany Powell-Wiley and colleagues in Circulation Research proposes that social determinants of health are upstream biological stressors, not demographic noise. On their account, these stressors physically reshape the neuro-endocrine-immune axis and in doing so drive cardiovascular disease.

Sam: [curious, leaning in, voice low] Most of us treat neighborhood deprivation as a confounder to adjust away. Is the proposal that it sits on the causal pathway itself? [[RP_SECTION:neuro-hematopoietic-axis-mechanism|Neuro-hematopoietic axis mechanism]]

Alex: [precise] That's the framing. The mechanism they lean on is the neuro-hematopoietic axis. Chronic stress signals from the amygdala drive the sympathetic nervous system to innervate the bone marrow, which responds with stress-induced leukopoiesis. The marrow overproduces inflammatory leukocytes, and those cells infiltrate and destabilize arterial plaques.

Sam: [thoughtful] That's a concrete route from social environment to atherosclerosis. But why doesn't the body dampen it? Inflammation normally has brakes. [[RP_SECTION:glucocorticoid-receptor-resistance|Glucocorticoid receptor resistance]]

Alex: [slower, teaching mode] That's where glucocorticoid receptor resistance comes in. Chronic HPA axis activation blunts the anti-inflammatory response. Cortisol keeps signaling, but the tissue stops listening. Think of a security guard kept on high alert for years who no longer responds to the calm-down signal and starts firing indiscriminately, with collateral damage to arterial tissue.

Sam: [probing] A feedback loop that's lost its sensitivity.

Alex: [confirming] Yes, and there's a second piece. Beta-adrenergic signaling shifts toward a pathway that promotes inflammatory cytokines. So the system is losing its brakes while the accelerator is being pushed. [[RP_SECTION:evidence-gaps-and-model-validation|Evidence gaps and model validation]]

Sam: [analytical] Here's my referee instinct, though. This is a review. It's assembling a mechanistic model, not testing the whole chain from deprivation index to plaque in one cohort. How much of the causal story is demonstrated, and how much is inferred?

Alex: [measured] That's the right pressure point, and the review itself points to it. The proposed pathway is plausible and the individual links are described, but the authors acknowledge a data gap. We lack longitudinal data connecting specific structural determinants, food insecurity for example, to these molecular markers in diverse cohorts. Without that, the end-to-end claim stays a model.

[interjecting—] Which matters for the clinical argument too. The draft framing is that standard guidelines miss something for marginalized patients because they target lipids and blood pressure.

Social Determinants of Cardiovascular Disease

Tiffany M. Powell-Wiley, Yvonne Baumer, Foster Osei Baah, Andrew S. Baez, Nicole Farmer, Christa T. Mahlobo, Mario A. Pita, Kameswari A. Potharaju, Kosuke Tamura, Gwenyth R. Wallen

Mar 4, 2022·4:10·zotero·Original Paper

Social Determinants of Health (SDoH)Cardiovascular Disease (CVD) PathogenesisHealth InequitiesHealth EquityStructural DeterminantsIntermediary Determinants

Listen

4 min

Briefing

Overview

This review addresses the critical need to better understand how social determinants of health (SDoH) contribute to cardiovascular disease (CVD). While SDoH—encompassing economic, social, environmental, and psychosocial factors—are known to influence health outcomes, the specific pathways linking these structural drivers to cardiovascular health remain understudied. The authors propose a new, equity-focused framework that centers on the lived experiences of marginalized populations to better inform research and clinical interventions.

A Framework for Health Equity

The authors argue that existing SDoH models often fail to account for the structural processes of marginalization, such as systemic racism, discrimination, and social exclusion. Their revised framework categorizes these determinants into two domains: structural (sociopolitical and economic contexts, including laws and policies) and intermediary (social and community contexts, such as food environments and housing stability). By focusing on these constructs, the framework aims to help researchers move beyond using race and ethnicity as mere proxies for social risk, instead identifying the specific structural drivers that create health disparities.

The Biology of Adversity

A central contribution of this paper is the exploration of the biological mechanisms connecting SDoH to CVD, termed the biology of adversity. Chronic exposure to social stressors—such as neighborhood violence, discrimination, and financial strain—activates the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis. This chronic activation leads to dysregulated stress hormone signaling, which promotes persistent systemic inflammation, alters immune cell function, and accelerates cellular aging (e.g., through telomere shortening). These biological sequelae directly contribute to the development of CVD risk factors like hypertension, obesity, and atherosclerosis.

Future Directions and Interventions

The authors provide a roadmap for integrating SDoH into clinical care and research. They advocate for multilevel, community-engaged interventions that address both individual social needs and upstream structural factors. The paper emphasizes that future research must employ mixed-methods approaches—combining rigorous quantitative data with qualitative insights—to fully capture the impact of lived experiences on cardiovascular health. By standardizing SDoH measures in electronic health records and clinical trials, the medical community can better tailor care to the needs of the most vulnerable populations.

Key Terms and Definitions

Social Determinants of Health (SDoH) — The economic, social, environmental, and psychosocial conditions in which people are born, live, learn, work, and age that influence health outcomes.
Structural Racism — Laws, policies, and practices embedded within societal norms that perpetuate discrimination and create systemic health inequities.
Biology of Adversity — The physiological and molecular pathways, such as chronic inflammation and cellular aging, through which social and environmental stressors are translated into physical disease.
Glucocorticoid Receptor Resistance — A condition where immune cells become desensitized to cortisol due to chronic stress, leading to a failure to suppress inflammation.
Activity Space — The geographic areas where individuals spend their time throughout the day, providing a more accurate measure of environmental exposure than residential location alone.

Abstract

Social determinants of health (SDoH), which encompass the economic, social, environmental, and psychosocial factors that influence health, play a significant role in the development of cardiovascular disease (CVD) risk factors as well as CVD morbidity and mortality. The COVID-19 pandemic and the current social justice movement sparked by the death of George Floyd have laid bare long-existing health inequities in our society driven by SDoH. Despite a recent focus on these structural drivers of health disparities, the impact of SDoH on cardiovascular health and CVD outcomes remains understudied and incompletely understood. To further investigate the mechanisms connecting SDoH and CVD, and ultimately design targeted and effective interventions, it is important to foster interdisciplinary efforts that incorporate translational, epidemiological, and clinical research in examining SDoH-CVD relationships. This review aims to facilitate research coordination and intervention development by providing an evidence-based framework for SDoH rooted in the lived experiences of marginalized populations. Our framework highlights critical structural/socioeconomic, environmental, and psychosocial factors most strongly associated with CVD and explores several of the underlying biologic mechanisms connecting SDoH to CVD pathogenesis, including excess stress hormones, inflammation, immune cell function, and cellular aging. We present landmark studies and recent findings about SDoH in our framework, with careful consideration of the constructs and measures utilized. Finally, we provide a roadmap for future SDoH research focused on individual, clinical, and policy approaches directed towards developing multilevel community-engaged interventions to promote cardiovascular health.

Social Determinants of Cardiovascular Disease: Research Paper Podcast